Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone for Vaginal Atrophy
NCT02460302Phase 2Withdrawn
- Sponsor
- Mount Sinai Hospital
- Start
- Dec 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of progesterone in atrophic vaginitis, sponsored by Mount Sinai Hospital. Planned start Dec 2016; status: withdrawn.
02
Drugs
progesterone
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on NCT02460302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460302.